These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18311434)

  • 1. Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study.
    Harmsze AM; Houte Mv; Deneer VH; Tupker RA
    Acta Derm Venereol; 2008; 88(2):108-12. PubMed ID: 18311434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxybutynin on exercise-induced sweating in healthy individuals.
    van Houte M; Harmsze AM; Deneer VH; Tupker RA
    J Dermatolog Treat; 2008; 19(2):101-4. PubMed ID: 18484428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].
    Maillard H; Fenot M; Bara C; Célérier P
    Ann Dermatol Venereol; 2011 Oct; 138(10):652-6. PubMed ID: 21978500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxybutynin: dry days for patients with hyperhidrosis.
    Mijnhout GS; Kloosterman H; Simsek S; Strack van Schijndel RJ; Netelenbos JC
    Neth J Med; 2006 Oct; 64(9):326-8. PubMed ID: 17057269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.
    Pariser DM; Krishnaraja J; Tremblay TM; Rubison RM; Love TW; McGraw BF
    J Drugs Dermatol; 2017 Feb; 16(2):127-132. PubMed ID: 28300854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eccrine sweat response in children with asthma.
    Oflu A; Soyer OU; Tuncer A; Sackesen C; Kalayci O
    Allergy; 2010 May; 65(5):645-8. PubMed ID: 19886927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Oxybutynin 10% Gel for the Treatment of Primary Focal Hyperhidrosis: A Randomized Double-blind Placebo-controlled Split Area Study.
    Artzi O; Loizides C; Zur E; Sprecher E
    Acta Derm Venereol; 2017 Oct; 97(9):1120-1124. PubMed ID: 28654131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis.
    Krogstad AL; Mork C; Piechnik SK
    Br J Dermatol; 2006 Jun; 154(6):1118-22. PubMed ID: 16704643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy.
    Costa Ada S; Leão LE; Succi JE; Perfeito JA; Filho Castelo A; Rymkiewicz E; Filho Aurelio Marchetti M
    Clinics (Sao Paulo); 2014 Feb; 69(2):101-5. PubMed ID: 24519200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
    Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
    Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial.
    Schollhammer M; Brenaut E; Menard-Andivot N; Pillette-Delarue M; Zagnoli A; Chassain-Le Lay M; Sassolas B; Jouan N; Le Ru Y; Abasq-Thomas C; Greco M; Penven K; Roguedas-Contios AM; Dupré-Goetghebeur D; Gouedard C; Misery L; Le Gal G
    Br J Dermatol; 2015 Nov; 173(5):1163-8. PubMed ID: 26114588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old.
    Wolosker N; Schvartsman C; Krutman M; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2014; 31(1):48-53. PubMed ID: 23627681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe night sweating treated by oxybutynin.
    Dias L; Martinot C; Vaillant G; Arnulf I
    J Clin Sleep Med; 2024 Jan; 20(1):169-172. PubMed ID: 38163944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical measurement of sweat activity.
    Tronstad C; Gjein GE; Grimnes S; Martinsen ØG; Krogstad AL; Fosse E
    Physiol Meas; 2008 Jun; 29(6):S407-15. PubMed ID: 18544832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of exercise on water balance in premenopausal physically active women.
    Weinheimer EM; Martin BR; Weaver CM; Welch JM; Campbell WW
    J Am Diet Assoc; 2008 Oct; 108(10):1662-7. PubMed ID: 18926131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.
    Fujimoto T; Terahara T; Okawa K; Inakura H; Hirayama Y; Yokozeki H
    J Am Acad Dermatol; 2023 Jul; 89(1):62-69. PubMed ID: 36990320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.